13F
← All fund report cards

FAYEZ SAROFIM & CO

13F equity value
$39.1B
Positions
294
Top 10 concentration
48.1%
Quarters / total new picks
32 / 283
13F equity value over time
$0M$22B$43B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.5% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 1.15, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.1%
t-stat
1.15
Quarterly win rate
56%
Annualized excess
+2.3%
$1 → follow vs universe
$2.46 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.06520180630: follow 1.15320180930: follow 1.24920181231: follow 1.20720190331: follow 1.22520190630: follow 1.38020190930: follow 1.52820191231: follow 1.12420200331: follow 1.25420200630: follow 1.40420200930: follow 1.93220201231: follow 2.17720210331: follow 2.44320210630: follow 2.58620210930: follow 2.29720211231: follow 1.96120220331: follow 1.95320220630: follow 1.80020220930: follow 1.95620221231: follow 1.94520230331: follow 1.97320230630: follow 2.02420230930: follow 2.18220231231: follow 2.07520240331: follow 1.93920240630: follow 2.25520240930: follow 2.16620241231: follow 2.08220250331: follow 2.12320250630: follow 2.26820250930: follow 2.15720251231: follow 2.461 0.84 1.81 2.79 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 294 · 2026 Q1

Ticker Value Weight QoQ
AAPL $3.5B
9.0%
TRIM
MSFT $2.8B
7.3%
HOLD
GOOG $2.2B
5.7%
HOLD
PM $1.8B
4.6%
HOLD
NVDA $1.7B
4.4%
ADD
AMZN $1.7B
4.3%
HOLD
XOM $1.4B
3.5%
TRIM
CVX $1.3B
3.3%
TRIM
META $1.2B
3.1%
ADD
KO $1.2B
2.9%
TRIM
JPM $920M
2.4%
HOLD
V $903M
2.3%
HOLD
ASML $878M
2.3%
HOLD
TSM $861M
2.2%
ADD
MCD $840M
2.1%
HOLD
TXN $672M
1.7%
TRIM
SPGI $650M
1.7%
HOLD
EPD $613M
1.6%
TRIM
BLK $612M
1.6%
ADD
MA $602M
1.5%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.